{
    "organizations": [],
    "uuid": "211b0b0d6bd8bd25b32f8615cfeec5412da19616",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fountain-biopharma-receives-china/brief-fountain-biopharma-receives-china-patent-idUSL4N1QC2O3",
    "ord_in_thread": 0,
    "title": "BRIEF-Fountain Biopharma receives China patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Fountain Biopharma Inc :\n* Says it received China patent for Anti-c mx antibodies capable of binding to human mige on blymphocytes\n* Patent number is ZL201510069440.7\nSource text in Chinese: goo.gl/T2aA1e\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-22T17:16:00.000+02:00",
    "crawled": "2018-02-23T15:55:44.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "fountain",
        "biopharma",
        "inc",
        "say",
        "received",
        "china",
        "patent",
        "mx",
        "antibody",
        "capable",
        "binding",
        "human",
        "mige",
        "blymphocytes",
        "patent",
        "number",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}